TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 2 | 5 | 0 | 8 | 11 | 33 | 11 | 13 |
| P | %wins | 100 | 50 | 50 | 50 | 100 | 50 | 67 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/10/14 16:52 | 1/10/14 | RPRX | Repros Therapeutics Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Cain Daniel F | CO | D | M.d | 96 | 9.60 | 7 | 10 | 999% | 11 | D | 342 | 23 | -2 | -13 | 34 | 12 | 10 | 4 | -3 | 4 | -8 | -26 | -20 | -56 | |
11/14/13 11:20 | 11/12/13 | RPRX | Repros Therapeutics Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Cain Daniel F | CO | D | P | 7 | 14.97 | 14 | 1 | 100 | 1 | D | 210 | 6 | -14 | -23 | -43 | -18 | -17 | -4 | 2 | -2 | 18 | 26 | 7 | -34 | |
7/27/06 20:10 | 7/27/06 | RPRX | Repros Therapeutics Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Cain Daniel F | CO | D | P | 17 | 8.34 | 0 | 2 | New | 2 | D | 128 | 84 | 57 | -31 | 0 | 5 | 7 | 4 | 7 | 2 | -3 | -4 | 58 | 56 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |